EV/EBITDA
-5.32
+0.77+12.64%
6 min ago
Summary:
Denali Therapeutics EV/EBITDA is currently -5.32, with a rise of +0.77 (+12.64%) during the most recent trading day. Over the past year, it has increased by +9.30 (+63.61%). DNLI EV/EBITDA is now -102.84% below its all-time high of 187.57.DNLI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DNLI EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +12.6% |
| 1 m1 month | +25.6% |
| 3 m3 months | +33.7% |
| 6 m6 months | +13.6% |
| ytdytd | +8.9% |
| 1 y1 year | +63.6% |
| 5 y5 years | +34.1% |
DNLI EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -5.32 | at high | -7.16 | +25.7% |
| 3 m | 3 months | -5.32 | at high | -9.09 | +41.5% |
| 6 m | 6 months | -5.32 | at high | -9.09 | +41.5% |
| 1 y | 1 year | -5.32 | at high | -17.64 | +69.8% |
| 3 y | 3 years | -5.32 | at high | -29.56 | +82.0% |
| 5 y | 5 years | 187.57 | -102.8% | -47.42 | +88.8% |
| alltime | all time | 187.57 | -102.8% | -58.31 | +90.9% |
Denali Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -5.32(-8.9%) |
| 2024 | -5.84(-63.5%) |
| 2023 | -15.99(+45.8%) |
| 2022 | -10.97(-39.7%) |
| Date | Value |
|---|---|
| 2021 | -18.19(-113.4%) |
| 2020 | 135.54(-1767.2%) |
| 2019 | -8.13(-83.1%) |
| 2018 | -48.22(+265.0%) |
| 2017 | -13.21 |
FAQ
- What is Denali Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Denali Therapeutics?
- What is DNLI EV/EBITDA year-to-date change?
- What is Denali Therapeutics EV/EBITDA year-on-year change?
What is Denali Therapeutics EV/EBITDA?
The current EV/EBITDA of DNLI is -5.32
What is the all time high EV/EBITDA for Denali Therapeutics?
Denali Therapeutics all-time high EV/EBITDA is 187.57
What is DNLI EV/EBITDA year-to-date change?
Denali Therapeutics EV/EBITDA has changed by +0.52 (+8.90%) since the beginning of the year
What is Denali Therapeutics EV/EBITDA year-on-year change?
Over the past year, DNLI EV/EBITDA has changed by +9.30 (+63.61%)